Asif Alavi

National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide

Bronwen E. Shaw, Antonio Martin Jimenez-Jimenez, Linda J. Burns et al. · Journal of Clinical Oncology · 2021 · 213 citations · Full text

Medicine, Hematology, Immunology +17

Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial

Bronwen E. Shaw, Antonio Martin Jimenez-Jimenez, Linda J. Burns et al. · Transplantation and Cellular Therapy · 2022 · 53 citations · Full text

Medicine, Hematology, Immunology +17

Preliminary Safety and Efficacy Results from Precizn-1: An Ongoing Phase 1/2 Study on Zinc Finger Nuclease-Modified Autologous CD34+ HSPCs for Sickle Cell Disease (SCD)

Asif Alavi, Lakshmanan Krishnamurti, Mehrdad Abedi et al. · Blood · 2021 · 26 citations

Medicine, Hematology, Molecular Medicine +12

Liver Graft‐Versus‐Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients

Dipenkumar Modi, Jing Christine Ye, Malini Surapaneni et al. · American Journal of Hematology · 2019 · 22 citations · Full text

Medicine, Hematology, Surgery +10

Pre-transplant hypomethylating agents do not influence post-transplant survival in myelodysplastic syndrome

Dipenkumar Modi, Seongho Kim, Vijendra K. Singh et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 16 citations · Full text

Medicine, Hematology, Chemotherapy +14